Constellation Software (CNSWF)
(Delayed Data from OTC)
$3,460.00 USD
+20.00 (0.58%)
Updated Aug 4, 2025 03:51 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CNSWF 3,460.00 +20.00(0.58%)
Will CNSWF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNSWF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNSWF
StoneCo Ltd. (STNE) Q1 Earnings Top Estimates
Is Constellation Software (CNSWF) Stock Outpacing Its Computer and Technology Peers This Year?
CNSWF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
Constellation Software (CNSWF) is an Incredible Growth Stock: 3 Reasons Why
What Makes Constellation Software (CNSWF) a New Strong Buy Stock
Other News for CNSWF
Janus Henderson Enterprise Fund Q2 2025 Commentary
Fidelity International Discovery Fund Q2 2025 Commentary
Akre Focus Fund Q2 2025 Commentary
Giverny Capital Asset Management Q2 2025 Letter
Highwood Value Partners H1 2025 Letter To Investors